Brief: Synact Pharma Applies For Patent For Ap1189 Within Covid-19

SynAct Pharma AB

03/04/2020 09:14

April 3 (Reuters) - SynAct Pharma AB  SYNACT.TE :
    * SYNACT PHARMA APPLIES FOR PATENT FOR AP1189 WITHIN COVID-19
    * SYNACT PHARMA AB - FILED A PATENT APPLICATION TO EUROPEAN PATENT OFFICE (EPO) COVERING USE
OF
AP1189 FOR TREATMENT OF COVID-19 INFECTION
    * SYNACT PHARMA AB - INTENDS TO INVESTIGATE ANTI-INFLAMMATORY DRUG CANDIDATE AP1189 AS
ADJUNCTIVE
THERAPY IN PATIENTS WITH COVID-19 INFECTION TO PREVENT ARDS

Source text for Eikon:  ID:nWkrc4Fmd0 
Further company coverage:  SYNACT.TE 

 (Gdansk Newsroom)
 ((Gdansk.newsroom@thomsonreuters.com; +48 58 778 51 10;))